Ganciclovir
Back to searchMolecule Structure
Scientific Name
Ganciclovir
Description of the Drug
Ganciclovir is a DNA polymerase inhibitor used to treat cytomegalovirus and herpetic keratitis of the eye.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01004
http://www.drugbank.ca/drugs/DB01004
Brand Name(s)
Cymevene, Cytovene, Ganciclovir, Ganzyk-rtu, Virgan, Vitrasert, Zirgan
Company Owner(s)
Roche Palo Alto Llc, Fresenius Kabi Usa Llc, Custopharm Inc, Steriscience Pte Ltd, Pharmascience Inc, Par Sterile Products Llc, American Regent Inc, Cheplapharm Arzneimittel Gmbh, Bausch And Lomb Inc, Exela Pharma Sciences Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human herpesvirus 1 DNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL1872 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3033 | |||
PharmGKB | PA449733 | |||
Human Metabolome Database | HMDB0015139 | |||
DrugBank | DB01004 | |||
PubChem: Thomson Pharma | 16217245 | 14798783 | 14749970 | |
PubChem | 135398740 | |||
Mcule | MCULE-9512761592 | |||
NMRShiftDB | 60021391 | |||
LINCS | LSM-5382 | |||
Nikkaji | J22.096E | |||
PDBe | GA2 | |||
BindingDB | 85707 | 50237614 | ||
EPA CompTox Dashboard | DTXSID8041032 | |||
DrugCentral | 1277 | |||
Brenda | 2899 | 166475 | 209607 | |
ChemicalBook | CB6203364 | |||
rxnorm | ZIRGAN | GANCICLOVIR SODIUM | GANCICLOVIR | CYTOVENE |
PubChem: Drugs of the Future | 12013652 | |||
ChEBI | 465284 | |||
ZINC | ZINC000000001505 |